CN114450018A - 具有预防或改善呼吸道疾病的功效的茶组合物及包含该茶组合物的药物组合物 - Google Patents
具有预防或改善呼吸道疾病的功效的茶组合物及包含该茶组合物的药物组合物 Download PDFInfo
- Publication number
- CN114450018A CN114450018A CN202080057132.1A CN202080057132A CN114450018A CN 114450018 A CN114450018 A CN 114450018A CN 202080057132 A CN202080057132 A CN 202080057132A CN 114450018 A CN114450018 A CN 114450018A
- Authority
- CN
- China
- Prior art keywords
- radix
- extract
- respiratory
- respiratory virus
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 56
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 11
- 208000023504 respiratory system disease Diseases 0.000 title description 5
- 241000700605 Viruses Species 0.000 claims abstract description 81
- 230000003097 anti-respiratory effect Effects 0.000 claims abstract description 36
- 230000000241 respiratory effect Effects 0.000 claims abstract description 20
- 201000010099 disease Diseases 0.000 claims abstract description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 11
- 239000000284 extract Substances 0.000 claims description 54
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- 239000002904 solvent Substances 0.000 claims description 27
- 235000013376 functional food Nutrition 0.000 claims description 19
- 230000036541 health Effects 0.000 claims description 19
- 241000711573 Coronaviridae Species 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 14
- 150000001298 alcohols Chemical class 0.000 claims description 10
- 239000004480 active ingredient Substances 0.000 claims description 9
- 235000013305 food Nutrition 0.000 claims description 9
- 241000756943 Codonopsis Species 0.000 claims description 7
- 241001633574 Adenophora stricta Species 0.000 claims description 5
- 241001529821 Agastache Species 0.000 claims description 5
- 241000208340 Araliaceae Species 0.000 claims description 5
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 5
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 5
- 235000008434 ginseng Nutrition 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 230000002265 prevention Effects 0.000 claims description 5
- 239000003826 tablet Substances 0.000 claims description 5
- 239000009636 Huang Qi Substances 0.000 claims description 4
- 235000005205 Pinus Nutrition 0.000 claims description 4
- 241000218602 Pinus <genus> Species 0.000 claims description 4
- 235000013361 beverage Nutrition 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 4
- 210000000582 semen Anatomy 0.000 claims description 4
- 239000000725 suspension Substances 0.000 claims description 4
- 241000709661 Enterovirus Species 0.000 claims description 3
- 241000628997 Flos Species 0.000 claims description 3
- 241000351643 Metapneumovirus Species 0.000 claims description 3
- 208000002606 Paramyxoviridae Infections Diseases 0.000 claims description 3
- 241000725643 Respiratory syncytial virus Species 0.000 claims description 3
- 235000009508 confectionery Nutrition 0.000 claims description 3
- 239000003085 diluting agent Substances 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 3
- 241000701161 unidentified adenovirus Species 0.000 claims description 3
- 241000712461 unidentified influenza virus Species 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 2
- 239000000443 aerosol Substances 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- 239000007924 injection Substances 0.000 claims description 2
- 238000002347 injection Methods 0.000 claims description 2
- 235000015110 jellies Nutrition 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000000829 suppository Substances 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 235000020542 functional tea Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 5
- 241001122767 Theaceae Species 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 64
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 54
- 238000000605 extraction Methods 0.000 description 50
- 241000234314 Zingiber Species 0.000 description 22
- 235000006886 Zingiber officinale Nutrition 0.000 description 22
- 235000008397 ginger Nutrition 0.000 description 22
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 20
- 238000000034 method Methods 0.000 description 18
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 16
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 16
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- 241000202807 Glycyrrhiza Species 0.000 description 12
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 12
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 11
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 11
- 229940010454 licorice Drugs 0.000 description 11
- 241000711484 Transmissible gastroenteritis virus Species 0.000 description 10
- 239000012046 mixed solvent Substances 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 229940002508 ginger extract Drugs 0.000 description 8
- 235000020708 ginger extract Nutrition 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 241001633680 Polygonatum odoratum Species 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000003809 water extraction Methods 0.000 description 6
- 241001061264 Astragalus Species 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 241000282412 Homo Species 0.000 description 5
- 235000013430 Pinus taiwanensis Nutrition 0.000 description 5
- 241000048269 Pinus taiwanensis Species 0.000 description 5
- 241001135549 Porcine epidemic diarrhea virus Species 0.000 description 5
- 241000245665 Taraxacum Species 0.000 description 5
- 235000006533 astragalus Nutrition 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000002798 polar solvent Substances 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 210000004233 talus Anatomy 0.000 description 5
- 238000002137 ultrasound extraction Methods 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- 235000009292 Asparagus cochinchinensis Nutrition 0.000 description 4
- 244000248539 Asparagus cochinchinensis Species 0.000 description 4
- 241000304370 Orostachys Species 0.000 description 4
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 4
- 240000004534 Scutellaria baicalensis Species 0.000 description 4
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 4
- 244000269722 Thea sinensis Species 0.000 description 4
- 230000000840 anti-viral effect Effects 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000012454 non-polar solvent Substances 0.000 description 4
- 239000000419 plant extract Substances 0.000 description 4
- 210000003501 vero cell Anatomy 0.000 description 4
- 230000005727 virus proliferation Effects 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 208000025721 COVID-19 Diseases 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 235000002723 Dioscorea alata Nutrition 0.000 description 3
- 235000007056 Dioscorea composita Nutrition 0.000 description 3
- 235000009723 Dioscorea convolvulacea Nutrition 0.000 description 3
- 235000005362 Dioscorea floribunda Nutrition 0.000 description 3
- 235000004868 Dioscorea macrostachya Nutrition 0.000 description 3
- 235000005361 Dioscorea nummularia Nutrition 0.000 description 3
- 235000005360 Dioscorea spiculiflora Nutrition 0.000 description 3
- 244000281702 Dioscorea villosa Species 0.000 description 3
- 244000249585 Elaeagnus conferta Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241000168720 Panax japonicus Species 0.000 description 3
- 235000003174 Panax japonicus Nutrition 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 235000008422 Schisandra chinensis Nutrition 0.000 description 3
- 240000006079 Schisandra chinensis Species 0.000 description 3
- 244000273928 Zingiber officinale Species 0.000 description 3
- 240000008866 Ziziphus nummularia Species 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 235000004879 dioscorea Nutrition 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000005194 fractionation Methods 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000000638 solvent extraction Methods 0.000 description 3
- 241001412627 Adenophora liliifolia Species 0.000 description 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 2
- 241000007126 Codonopsis pilosula Species 0.000 description 2
- 241001660870 Cyrtomium Species 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 235000002722 Dioscorea batatas Nutrition 0.000 description 2
- 240000001811 Dioscorea oppositifolia Species 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241000379610 Lachnus Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000025370 Middle East respiratory syndrome Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000283898 Ovis Species 0.000 description 2
- 241001080798 Polygala tenuifolia Species 0.000 description 2
- 241001162994 Rugosus Species 0.000 description 2
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 2
- 241000207929 Scutellaria Species 0.000 description 2
- 235000010586 Sophora japonica Nutrition 0.000 description 2
- 244000046101 Sophora japonica Species 0.000 description 2
- 241000292546 Taraxacum mongolicum Species 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 241000234299 Zingiberaceae Species 0.000 description 2
- FSLPMRQHCOLESF-UHFFFAOYSA-N alpha-amyrenol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C FSLPMRQHCOLESF-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229940076810 beta sitosterol Drugs 0.000 description 2
- JFSHUTJDVKUMTJ-QHPUVITPSA-N beta-amyrin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C JFSHUTJDVKUMTJ-QHPUVITPSA-N 0.000 description 2
- QQFMRPIKDLHLKB-UHFFFAOYSA-N beta-amyrin Natural products CC1C2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C)CCC1(C)C QQFMRPIKDLHLKB-UHFFFAOYSA-N 0.000 description 2
- PDNLMONKODEGSE-UHFFFAOYSA-N beta-amyrin acetate Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC23C)C1(C)C PDNLMONKODEGSE-UHFFFAOYSA-N 0.000 description 2
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 230000006806 disease prevention Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000002038 ethyl acetate fraction Substances 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 2
- 239000000401 methanolic extract Substances 0.000 description 2
- GDGDGXJBOLVFBL-UHFFFAOYSA-N mosloflavanone Natural products C1C(=O)C=2C(O)=C(OC)C(OC)=CC=2OC1(O)C1=CC=CC=C1 GDGDGXJBOLVFBL-UHFFFAOYSA-N 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- ZFKKRRMUPBBYRS-UHFFFAOYSA-N norwogonin Chemical compound OC=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=CC=C1 ZFKKRRMUPBBYRS-UHFFFAOYSA-N 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- LKOJGSWUMISDOF-UHFFFAOYSA-N oroxylin A Chemical compound C=1C(=O)C2=C(O)C(OC)=C(O)C=C2OC=1C1=CC=CC=C1 LKOJGSWUMISDOF-UHFFFAOYSA-N 0.000 description 2
- PGZUMBJQJWIWGJ-ONAKXNSWSA-N oseltamivir phosphate Chemical compound OP(O)(O)=O.CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1 PGZUMBJQJWIWGJ-ONAKXNSWSA-N 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 244000132619 red sage Species 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- 229950005143 sitosterol Drugs 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 229940061367 tamiflu Drugs 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000001841 zingiber officinale Substances 0.000 description 2
- XWMMEBCFHUKHEX-MRTCRTFGSA-N (+)-Taraxasterol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC[C@]1(C)[C@@H]2CC[C@H]2[C@@H]3[C@H](C)C(=C)CC[C@]3(C)CC[C@]21C XWMMEBCFHUKHEX-MRTCRTFGSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- QMKPCZNFLUQTJZ-UHFFFAOYSA-N (4aR)-10c-Hydroxy-1t.2c.4ar.6at.6bc.9.9.12ac-octamethyl-(8atH.12btH.14acH.14btH)-docosahydro-picen Natural products CC1CCC2(C)CCC3(C)C(CCC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C QMKPCZNFLUQTJZ-UHFFFAOYSA-N 0.000 description 1
- WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 241001633583 Adenophora Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 244000003416 Asparagus officinalis Species 0.000 description 1
- 235000005340 Asparagus officinalis Nutrition 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241000193749 Bacillus coagulans Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- FXNFHKRTJBSTCS-UHFFFAOYSA-N Baicalein Natural products C=1C(=O)C=2C(O)=C(O)C(O)=CC=2OC=1C1=CC=CC=C1 FXNFHKRTJBSTCS-UHFFFAOYSA-N 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 241000711443 Bovine coronavirus Species 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 241001678559 COVID-19 virus Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282832 Camelidae Species 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 208000001528 Coronaviridae Infections Diseases 0.000 description 1
- 241000220284 Crassulaceae Species 0.000 description 1
- 244000164480 Curcuma aromatica Species 0.000 description 1
- 235000003398 Curcuma aromatica Nutrition 0.000 description 1
- 240000007371 Cuscuta campestris Species 0.000 description 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 1
- 241001508399 Elaeagnus Species 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 241000510678 Falcaria vulgaris Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 102000002812 Heat-Shock Proteins Human genes 0.000 description 1
- 108010004889 Heat-Shock Proteins Proteins 0.000 description 1
- 206010020843 Hyperthermia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 235000006350 Ipomoea batatas var. batatas Nutrition 0.000 description 1
- 241000334160 Isatis Species 0.000 description 1
- 241000721662 Juniperus Species 0.000 description 1
- 235000014556 Juniperus scopulorum Nutrition 0.000 description 1
- 235000014560 Juniperus virginiana var silicicola Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 235000000665 Lycianthes asarifolia Nutrition 0.000 description 1
- 241000866517 Lycianthes asarifolia Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 240000002624 Mespilus germanica Species 0.000 description 1
- 235000017784 Mespilus germanica Nutrition 0.000 description 1
- 235000000560 Mimusops elengi Nutrition 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 241000219925 Oenothera Species 0.000 description 1
- 235000004496 Oenothera biennis Nutrition 0.000 description 1
- 241000304368 Orostachys fimbriata Species 0.000 description 1
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 1
- 241000282316 Paguma Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 241000756042 Polygonatum Species 0.000 description 1
- 235000008737 Polygonatum biflorum Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241001092489 Potentilla Species 0.000 description 1
- 241001428933 Rat coronavirus Species 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241000315672 SARS coronavirus Species 0.000 description 1
- 235000008691 Sabina virginiana Nutrition 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 239000010404 Scutellaria baicalensis extract Substances 0.000 description 1
- 235000019084 Selinum monnieri Nutrition 0.000 description 1
- 244000296102 Selinum monnieri Species 0.000 description 1
- 206010040849 Skin fissures Diseases 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 201000005485 Toxoplasmosis Diseases 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 235000007837 Vangueria infausta Nutrition 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- HIMJIPRMECETLJ-UHFFFAOYSA-N Wogonin Natural products COc1cc(O)c(O)c2C(=O)C=C(Oc12)c3ccccc3 HIMJIPRMECETLJ-UHFFFAOYSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000012675 alcoholic extract Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 239000012223 aqueous fraction Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000019206 astragalus extract Nutrition 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 229940054340 bacillus coagulans Drugs 0.000 description 1
- UDFLTIRFTXWNJO-UHFFFAOYSA-N baicalein Chemical compound O1C2=CC(=O)C(O)=C(O)C2=C(O)C=C1C1=CC=CC=C1 UDFLTIRFTXWNJO-UHFFFAOYSA-N 0.000 description 1
- 229940015301 baicalein Drugs 0.000 description 1
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 1
- 229960003321 baicalin Drugs 0.000 description 1
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000002021 butanolic extract Substances 0.000 description 1
- 239000002034 butanolic fraction Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 238000001516 cell proliferation assay Methods 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 239000002036 chloroform fraction Substances 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 229960003677 chloroquine Drugs 0.000 description 1
- WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Natural products ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 description 1
- 239000008845 cholagoga Substances 0.000 description 1
- 229940124571 cholagogue Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000007398 colorimetric assay Methods 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000002380 cytological effect Effects 0.000 description 1
- 229940067866 dandelion extract Drugs 0.000 description 1
- 235000020691 dandelion extract Nutrition 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- -1 etc. Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000020251 goat milk Nutrition 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 239000002044 hexane fraction Substances 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000000055 hyoplipidemic effect Effects 0.000 description 1
- 230000036031 hyperthermia Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002032 methanolic fraction Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 238000004161 plant tissue culture Methods 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- NGFFRJBGMSPDMS-UHFFFAOYSA-N psi-Taraxasterol Natural products CC12CCC(O)C(C)(C)C1CCC1(C)C2CCC2C3C(C)C(C)=CCC3(C)CCC21C NGFFRJBGMSPDMS-UHFFFAOYSA-N 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000005412 red sage Nutrition 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000001520 savin Nutrition 0.000 description 1
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 231100000338 sulforhodamine B assay Toxicity 0.000 description 1
- 238000003210 sulforhodamine B staining Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000001845 taraxacum officinale leaf extract Substances 0.000 description 1
- HUTYZQWCTWWXND-NCTFTGAASA-N taraxasterol Natural products C[C@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)C[C@H](O)[C@@]2(C)CCC1=C HUTYZQWCTWWXND-NCTFTGAASA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 230000007502 viral entry Effects 0.000 description 1
- 230000009447 viral pathogenesis Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- XLTFNNCXVBYBSX-UHFFFAOYSA-N wogonin Chemical compound COC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=CC=C1 XLTFNNCXVBYBSX-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/068—Chewing gum characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/10—Marmalades; Jams; Jellies; Other similar fruit or vegetable compositions; Simulated fruit products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/237—Notopterygium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/342—Adenophora
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/43—Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8965—Asparagus, e.g. garden asparagus or asparagus fern
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F2200/00—Special features
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Virology (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Inorganic Chemistry (AREA)
- Insects & Arthropods (AREA)
- Physiology (AREA)
- Animal Husbandry (AREA)
- Neurosurgery (AREA)
- Zoology (AREA)
- Pulmonology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
本发明涉及抗呼吸道病毒组合物,尤其是茶组合物,并且提供了具有治疗和预防呼吸道病毒相关疾病的功效的天然组合物。
Description
技术领域
本发明涉及抗呼吸道病毒组合物,尤其是茶组合物,并且提供了具有治疗和预防呼吸道病毒相关疾病的功效的天然组合物。
背景技术
一般而言,病毒的起源几乎始于人类历史,并且已经极大发展至今,其变异给人类带来了巨大的痛苦。特别是从果子狸传播的病毒因表现出被称为SARS的巨大毒性而给人类带来了巨大的痛苦,这种病毒被称为达菲的植物提取物所征服。由沙漠中的骆驼繁殖的MERS让人类感到恐惧,但也被从诸如达菲的植物中提取的药物所征服。然而目前的情况是,MERS仍处于无休止的潜伏期。
特别是,目前席卷全球的COVID-19是一种由来自马蹄蝠到野鼠的病毒组合产生的病毒。在2015年未能通过研究开发疫苗和疗法之后,COVID-19于2020年开始出现在地球上并已大规模传播。人类社会目睹了这种巨大的蔓延,在努力开发疫苗或疗法的同时,人类非常窘迫。此外,除了诸如洗手和戴口罩等非常前现代的方法中的原始应对外,没有特定的对策。在发明多种食品的过程中,发现可以从大青叶中检测出氯喹成分,并且在研究中,氯喹成分很容易被提取出来并与其它原料混合。
特别是,在认为人类永远无法解决不断发生的病毒的情况下,对病毒的研究似乎有所松动或被忽视,但遗憾的是,许多人都在与恐惧和疾病作斗争。对此,通过持续认真的研究,发现重要的是预防和捕获不断变异的病毒的最终终点,并且还发现由此产生的突变病毒也被杀死,并且发明了天然茶用于预防具有二级和三级突变的病毒以及用于抗病毒用途。
发明内容
技术问题
本发明的一个目的是提供一种有效治疗和预防由呼吸道病毒,特别是突变病毒如COVID-19的出现引起的疾病的天然组合物。
本发明的另一个目的是提供一种无副作用的抗呼吸道病毒药物组合物。
本发明的又一个目的是提供一种无副作用的抗呼吸道病毒保健功能食品。
问题的解决方案
根据一个实施方案,当呼吸道病毒是选自由腺病毒、偏肺病毒、鼻病毒、副流感病毒、流感病毒、呼吸道合胞病毒和冠状病毒组成的组中的一种或多种时,抗呼吸道病毒组合物更有效。
根据一个实施方案,呼吸道病毒优选是冠状病毒。
根据一个实施方案,可以通过使用选自水和具有1至4个碳原子的醇的一种或多种溶剂来提取大青叶提取物。
根据一个实施方案,所述抗呼吸道病毒组合物还可包含选自由以下组成的组的一种或多种的提取物:羊乳参天门冬玉竹黄芪蒲公英黄芩干姜山药人参甘草和枣党参苍术贯众羌活藿香陈皮五味子枸杞槐花菟丝子丹参蛇床子远志和郁金
抗呼吸道病毒组合物优选作为保健功能食品提供,并且优选以茶组合物的形式使用。
为实现本发明的目的,本发明可包括:根据本发明的抗呼吸道病毒组合物;和药学上可接受的载体、赋形剂或稀释剂。
根据一个实施方案,药物组合物可具有选自由以下组成的组的剂型:片剂、丸剂、散剂、颗粒剂、胶囊剂、混悬乳剂、糖浆剂、气雾剂、外用制剂、栓剂和注射剂。
根据一个实施方案,该药物组合物可用于治疗和预防抗呼吸道病毒相关疾病。
根据一个实施方案,可以包括根据本发明的抗呼吸道病毒组合物和食品学上可接受的补充添加剂。
根据一个实施方案,保健功能食品可具有选自由以下组成的组的剂型:粉剂、颗粒剂、片剂、胶囊剂、糖果、口香糖、果冻和饮料。
根据一个实施方案,该保健功能食品可用于治疗和预防抗呼吸道病毒相关疾病。
本公开的有益效果
根据本发明的抗呼吸道病毒组合物可适用于多种呼吸道病毒,特别是可以对由病毒突变体产生的突变病毒也有效。因此,抗呼吸道病毒组合物可以快速应对以连续突变形式出现的病毒。此外,持续使用时,可增强对各种病毒的免疫力,从而保持健康状态。
根据本发明的抗呼吸道病毒组合物可以提供一种药物组合物,其对呼吸道病毒相关疾病的治疗或预防有效,并且由天然物质制成,因此不会有副作用。
根据本发明的抗呼吸道病毒组合物可以提供一种保健功能食品,其对呼吸道病毒相关疾病的预防有效,并且在持续使用时可以增强免疫力。
具体实施方式
在下文中,将更详细地描述本发明。
当呼吸道病毒选自由腺病毒、偏肺病毒、鼻病毒、副流感病毒、流感病毒、呼吸道合胞病毒和冠状病毒组成的组时,抗呼吸道病毒组合物更有效。
呼吸道病毒可以是冠状病毒,特别是突变病毒,更特别是COVID19病毒。
冠状病毒是属于冠状病毒科的病毒,并且很多种疾病由冠状病毒感染引起。冠状病毒是一种RNA病毒,其造成哺乳动物和鸟类的呼吸系统疾病、消化系统疾病、肝脏疾病和脑部疾病[Thomas M Gallagher TM,and Michael J Buchmeier MJ(2001)CoronavirusSpike Proteins in Viral Entry and Pathogenesis Virology,279(2):371-374]。冠状病毒是引起普通感冒的病毒之一(Baker SCPediatric Infect Dis J(2004)23(11):1049-1050),但SARS病毒也是冠状病毒的一种。SARS病毒于2002年首次出现,到2003年春季,全球32个国家约9000名重症急性呼吸道疾病患者具有约15%的高死亡率。此外,冠状病毒也会给畜牧业造成严重的经济损失。另一种冠状病毒,猪流行性腹泻病毒(PEDV),是一种高传染性病毒性疾病,其侵入胃肠道引起呕吐和腹泻导致的脱水以及高热并且具有高死亡率,从而造成重大经济损失[Duarte M,Laude H(1994)Sequence of the spike protein of theporcineepidemic diarrhoea virus J Gen Virol,75(Pt 5):1195-200]。此外,在猪中具有高死亡率的猪传染性胃肠炎病毒(TGEV)也属于冠状病毒,其在不同动物中引起多种疾病,包括引起肝炎的小鼠冠状病毒、引起严重呼吸道疾病的大鼠冠状病毒、和引起神经系统疾病的牛冠状病毒[BrianDA,Baric RS Curr Top Microbiol Immunol(2005)287:1-30]。
晚红瓦松(Orostachys japonicus),也称为顿叶瓦松(Orosrachysmalacophyllus)是景天科植物,附着而栖息于山中向阳的岩石裂缝或传统房屋的瓦片和石墙上。然而,如今晚红瓦松已难觅踪迹,濒临灭绝,因此,为了药用,晚红瓦松是人工栽培和繁殖的。自古以来,晚红瓦松就用于治疗痔疮、肝炎、湿疹、痢疾腹泻、痔疮、疖疮、烧伤等,并且已知将其擦在疖子或伤口上可有效吸收脓液。还知道晚红瓦松有效促进血液流动、镇痛、免疫、皮炎、促进毛发生长、皮肤皲裂皮炎。
可用于制备晚红瓦松提取物的提取溶剂可以包括例如水、C1-C4低级醇、丙酮、乙酸乙酯、乙酸丁酯和1,3-丁二醇,其可以是单独或组合使用。在一个实施方案中,提取溶剂是乙醇,更具体地约70%乙醇。提取溶剂的量为晚红瓦松干重的约1至15倍,并且可为5至12倍或10倍,但不限于此。另外,作为提取方法,可以采用热水提取、冷提取、回流冷却提取、超声波提取等,并且提取可以重复一次或多次。此外,提取温度没有特别限制,只要不去除晚红瓦松的有用成分的有效活性即可。在一种实施方式中,优选通过在室温下浸渍进行提取。
根据本发明的一个实施方案,可以进一步包括沙参提取物。
沙参提取物,即沙参叶提取物,可以用但不限于选自由以下组成的组的一种溶剂提取:水、具有1至4个碳原子的低级醇及其混合物,并且优选用乙醇提取。
根据本发明的一个实施方案,还可以包含选自由以下组成的组的一种或更多种的提取物:羊乳参、天门冬、玉竹、黄芪、蒲公英、黄芩、干姜、山药、人参、甘草和枣、党参、苍术、贯众、羌活、藿香、陈皮、五味子、枸杞、槐花、菟丝子、丹参、蛇床子、远志和郁金。
可以包含羊乳参提取物作为活性成分以进一步增强抗呼吸道病毒组合物的功效。本发明的发酵羊乳参提取物可以通过多种方法制备,可以包括例如获得来自通过使用芽孢杆菌属的特定微生物的羊乳参发酵产物的提取物的方法,或通过使用芽孢杆菌属的特定微生物发酵羊乳参提取物的方法。此处,芽孢杆菌属的特定微生物选自枯草芽孢杆菌(Bacillus subtilis)、凝结芽孢杆菌(Bacillus coagulans)或其混合物。此外,为了获得本发明的发酵羊乳参提取物,可以将羊乳参的各种器官或部位,例如叶、花、根、茎、根茎、果实、种子等用作原材料,并且其中,优选使用羊乳参的根。同时,为了从羊乳参获得发酵羊乳参提取物,需要进行提取工序,并且作为提取方法,可以使用本领域已知的一般提取方法,例如溶剂提取法。采用溶剂提取法制备发酵羊乳参提取物时可使用的提取溶剂可以选自由以下组成的组:水、C1-C4低级醇(例如甲醇、乙醇、丙醇和丁醇)或作为其混合物的含水低级醇、丙二醇、1,3-丁二醇、甘油、丙酮、乙醚、乙酸乙酯、乙酸丁酯、二氯甲烷、氯仿、己烷及其混合物,其中优选选择水、醇或其混合物。当使用水作为提取溶剂时,水优选为热水。另外,当使用醇作为提取溶剂时,醇优选为C1-C4低级醇,更优选选自甲醇和乙醇中的低级醇。另外,当使用含水醇作为提取溶剂时,其含量优选为50%至90%。
通过以正己烷、二氯甲烷、乙酸乙酯和正丁醇的顺序对用水、醇或其混合物提取的天门冬(Asparagus cochinchinensis)提取物进行进一步系统性分级,本发明可以包含作为活性成分的二氯甲烷、乙酸乙酯,或用正丁醇分级的乙酸乙酯或正丁醇级分作为活性成分。对于天门冬根,可以使用栽培的或市售的,而没有限制。此外,根据本发明的天门冬提取物可以按以下方式制备。将天门冬根用水彻底清洗,然后在阴凉处和室温下干燥7天。将干燥的天门冬根粉碎并且然后放入提取容器中,然后在适当温度下用提取溶剂提取一定时间。得到天门冬提取物后,可以用滤纸等除去固形物,可以离心混悬液并且可以减压过滤上清液。提取溶剂可以是水、醇或其混合物,优选选自C1-C4低级醇或其混合溶剂的溶剂,更优选使用70%乙醇,但不限于此。提取溶剂的量为天门冬根干重的2至10倍。
作为提取方法,可以使用诸如热水提取、浸渍提取、回流冷却提取和超声波提取的提取方法,并且优选地可以通过使用热水提取法进行提取1至5次。提取过程中,提取温度优选为50℃至100℃,并且更优选为50℃至60℃。提取时间为1至4小时,优选2小时。
关于玉竹(Polygonatum odoratum)提取物,玉竹有多种类型,包括毛筒玉竹 二苞黄精等,并且在韩国,有18种玉竹,包括16个种和2个变种(1995),二者均可用于食用、观赏和药用(1991)。玉竹的其他名称可能包括玉树萎蕤黄精玉竹黄芝小笔管叶仙人饭菟竹怪物花陈黄精等。另外,根据本发明的方法可以使用的玉竹可以是任何种类玉竹,并且可以通过主要在深秋和早春采集其根并彻底清洗来使用。
作为用于产生根据本发明的玉竹提取物的方法,可以使用公知的方法。例如,将玉竹根等采集然后切成未加工的根形式的小块,或者在阳光下自然干燥或以机械方式强行干燥后切成小块,然后添加极性溶剂如水、甲醇、乙醇、丁醇和非极性溶剂如乙醚、己烷和氯仿,并且在室温下浸提或温提。
在本发明的一个优选实施方案中,从通过将玉竹在甲醇溶剂中在80℃下加热48小时然后提取制备的丁醇层中获得的提取物表现出良好的生理活性,例如降血糖作用和降低血脂作用(总胆固醇和甘油三酯,P<001)。更具体地,本发明人将干燥的玉竹和甲醇放入研磨机中粉碎,然后将粉碎的玉竹-甲醇溶液通过连接冷却器和机械搅拌器在80℃水浴中48小时,重复提取1-3次,将上述过程得到的提取溶液使用过滤器过滤,得到甲醇层。然后使用减压装置去除甲醇层中所含的甲醇,将通过上述过程得到的甲醇提取物按甲醇提取物:H2O:甲醇:提取溶剂=10:9:1:10的比例混合。然后,使用己烷、氯仿、正丁醇按该顺序作为提取溶剂依次进行提取,最终得到具有药理作用的丁醇提取物。
黄芪(Astragali radix)提取物可以采用本领域已知的黄芪提取方法进行提取,并且可以是例如溶剂提取法,但不限于此。此外,黄芪提取物可以通过使用柱色谱进一步进行额外的分级过程而制备为纯化级分。对于待提取的黄芪,可以购买和使用市售的黄芪,并且优选地购买的黄芪在进行提取工序前去除土壤等异物后使用。
蒲公英(Dandelion;Taraxacum playtcarpum H DAHLST)是菊科多年生草本蒲公英的露头,并且在其根中含有蒲公英甾醇(taraxasterol)、胆碱、菊粉、果胶等,特别是蒲公英醇(taraxol)、蒲公英赛醇(taraxerol)、Φ-蒲公英甾醇、蒲公英甾醇、β-香树精(β-amyrin)、豆甾醇、β-谷甾醇、胆碱、有机酸、果糖、维生素C等。对于蒲公英的药理作用,已知蒲公英对胃炎等有效。蒲公英提取物可以通过本领域已知的方法提取,也可以通过本发明公开的方法获得,例如用水或有机溶剂提取法。
黄芩(Scutellaria baicalensis Georgi)是唇形科的多年生植物,在中国、日本和韩国被广泛用作药用植物。关于主要功效,已知黄芩对炎症、呼吸道感染和消化道感染有效。已知黄芩的主要成分包括黄芩素、黄芩苷、汉黄芩素、去甲汉黄芩素、木蝴蝶素A(oroxylin A)、β-谷甾醇、荠苧黄酮(mosloflavone)等。本发明的黄芩提取物可如下制备。在将黄芩的干燥前端清洗和切碎后,与选自水(包括纯净水)、具有1至4个碳原子的低级醇如甲醇、乙醇、丁醇或其混合溶剂,优选水、甲醇、乙醇及其混合溶剂的溶剂多次混合,然后超声提取、热水提取、常温提取或回流提取,优选常温提取,重复进行约1至20次,优选2至10次:在30℃至150℃,优选在室温下,持续12小时至30天,优选1天至7天。结果,将获得的提取液过滤、减压浓缩并干燥,从而获得本发明的粗提取物。
如本文所用,术语“姜(Zingiber officinal)”是原产于亚洲热带的多年生草本,属于姜科姜属。姜科主要分布于热带地区,全世界有47个属约1400个种。约50个种的姜分布于东亚、印度、马来西亚等地。在韩国,种植姜属的襄荷和姜,种植姜花属中的姜花,并且襄荷花属中的襄荷花生长在韩国南部岛屿的森林土壤中。姜高约40至100cm,其根茎为根部,多汁肥厚、略扁平和呈水平延伸的圆形。姜的根茎为块状分枝的,呈黄色,气味芳香,味辛辣。姜的叶为互生叶序,一分为二,没有叶柄,茎周围有长叶鞘。姜的叶片呈线状披针形,长15-20cm,宽约2cm,叶尖渐尖,基部狭窄,有光泽,无毛。姜的花为淡黄色,穗状花序浓密,长约7cm。姜的花在7-9月开花,但栽培花很少开花。姜的结果期为12月至次年1月。姜的干燥根茎称干姜,其根茎软木皮称姜壳,其叶称姜叶,均用于医药用途。在本发明中,可以优选使用干姜。
本发明中,姜提取物可通过将姜清洗、干燥和粉碎;用选自水、C1-C4低级醇或其混合溶剂的溶剂对粉碎的姜进行提取来获得。姜提取物可以包括使用选自由以下组成的组的溶剂提取的产物:水、C1-C4低级醇及其混合溶剂,优选甲醇或乙醇,更优选甲醇。此外,在本发明中,提取物还包括提取处理得到的提取物、提取物的稀释或浓缩溶液、提供干燥提取物得到的干燥产物,或这些粗产物或纯化产物中的任一种。
提取方法没有特别限制,可以在室温下或通过在活性成分不被破坏或破坏程度最小的条件下加热来提取活性成分。更具体地说,本发明的姜提取物的获得方法如下。在提取干姜时,作为提取溶剂,使用体积为干姜干重的约2至20倍、优选约3至5倍的水、C1-C4低级醇如甲醇、乙醇、丁醇等的极性溶剂,或其混合比例为1:01至约1:10的混合溶剂。提取通过使用提取方法如摇动提取、热水提取、冷提取、回流冷却或超声提取等在20至100,优选25至35的温度下进行约5小时至10天,优选5-48小时。根据本发明的一个具体实施方案,将姜的自然干燥粉末在室温下用甲醇提取后,将提取物用滤纸过滤,并且通过在真空下蒸发和浓缩来提取。
姜提取物可以从天然、杂交和变种植物的各种器官中提取,并且可以从例如根、茎、叶和花以及植物组织培养物中提取。根据本发明的一个具体实施方案,回收通过向姜的干燥根中加入甲醇并混合得到的混合物,然后浓缩和冷冻干燥来制备姜提取物。
在本发明中,可以通过将姜提取物混悬于甲醇中,然后用极性溶剂或非极性溶剂对其进行分级,分别得到极性溶剂级分和非极性溶剂级分来获得姜提取物的级分。作为本发明的具体实施方案,作为溶剂级分,可以提供MeOH级分、水级分、乙腈级分、正己烷级分、乙酸乙酯级分或氯仿级分。根据本发明的一个具体实施方案,通过使用CHCl3-MeOH洗脱的硅胶柱色谱对姜提取物进行分级来获得姜级分。此外,溶剂级分也可以通过使用由选自极性溶剂如H2O、乙腈、甲醇、乙醇、丙醇或异丙醇和非极性溶剂如乙酸乙酯、正己烷、二氯甲烷或氯仿的两种或更多种组成的混合溶剂作为流动相的柱色谱分离,然后通过分离对预防和治疗弓形体病有效的活性成分来使用。
山药(Dioscorea batatas)是百合科多年生单子叶植物,又名山芋或薯囊,原产于中国,作为药材栽培,并且野外生长在山区。山药的块茎含有15%至20%的淀粉为主要成分和各种成分,包括各种氨基酸如精氨酸、组氨酸、赖氨酸和色氨酸,以及矿物质如钙、钠、镁和钾,以及维生素B1和维生素C。在本发明中,使用山药的块根。
甘草(Glycyrrhiza uralensis)是豆科多年生植物,原产于或栽培于中国北部、西伯利亚、意大利南部、满洲和蒙古。甘草是一种用作镇咳药的药草,同时作为降低毒性的成分包含在所有草药处方中(Rauchensteiner F et al,JPharmBiomedAnal,38(4),pp.594-600,2005),并且在欧洲,甘草也可用于使烟草、口香糖和糖果变甜。根据最近的一项研究结果,甘草减轻对肾脏的氧化损伤(YOKOZAWA T.et al,FreeRadic Res,39(2),pp.203-211,2005),并且已经证实甘草还具有保护被镉损伤的肝细胞的作用(KIM S.C.et al,Toxicology,197(3),pp.239-251,2004)。
在本发明中,甘草可以商业购买和使用,或在自然界中直接收获或生长。在本发明中,可以购买和使用市售的甘草,或可以使用从自然界直接收获或生长的甘草。在甘草提取物的制备方法中,可以采用本领域常用的提取方法,例如超声提取、过滤、回流提取等。优选地,甘草可以是通过将已经通过清洗和干燥去除异物的甘草粉碎,并用水、C1-C4醇或其混合溶剂提取甘草干燥产物而获得的提取物,更优选地用C1-C4醇提取的提取物,并且最优选用甲醇或乙醇提取的提取物。此处,提取溶剂优选为甘草干重的2至20倍。例如,在切碎后,可以将甘草干燥产物放入提取容器中,可以向其中加入C1-C4低级醇或其混合溶剂,优选甲醇或乙醇,并且在室温下放置一段时间,然后过滤,从而获得醇提取物。这里,提取优选在室温下放置一周,然后可以另外进行诸如浓缩或冷冻干燥的方法。
枣是自古以来的保健食品,营养丰富,并且与甘草一起是东方医学的重要成分。据报道,枣基本上含有大量的碳水化合物和抗坏血酸,并且包含作为药用成分的各种甾醇、生物碱、皂苷、维生素、有机酸、氨基酸等,并且其药理作用,如通便、利尿、滋补、利胆、兴奋、恢复体力、祛痰、抗炎等作用也有报道和鉴定,使枣在医药工业中得到广泛应用。由于农产品进口开放,作为市场受到蚕食的苹果和葡萄的替代作物而备受关注的枣,正在被推广为高收入果树,种植面积和产量逐渐增加。
根据本发明给的实施方案添加的党参、苍术、贯众、羌活、藿香、陈皮、五味子、枸杞、槐花、菟丝、丹参、蛇床子、远志和郁金的提取物可以通过本领域技术人员已知的方法提取。
本发明的组合物还可包含蜂蜜。
根据本发明的抗呼吸道病毒组合物优选包含基于总组合物的10至30重量%的晚红瓦松提取物。
根据本发明的抗呼吸道病毒组合物优选以基于总组合物的5至15重量%的量被包含。
根据本发明的抗呼吸道病毒组合物优选地以2-6:1-3重量份的比例包含晚红瓦松提取物和沙参提取物。
根据本发明的一个实施方案的抗呼吸道病毒组合物优选包含选自由以下组成的组的至少一种:羊乳参、天门冬、玉竹、黄芪、蒲公英、黄芩、干姜、山药、人参、甘草和枣、党参、苍术、贯众、羌活、藿香、陈皮、五味子、枸杞、槐花、菟丝子、丹参、蛇床子、远志和郁金,其量基于组合物的总重量为50至70重量%。
根据本发明的另一方面,可以通过在根据本发明的抗呼吸道病毒组合物中进一步加入药学上可接受的载体、赋形剂或稀释剂来提供抗呼吸道病毒的药物组合物。
本发明提供了包含所述抗呼吸道病毒食品组合物的保健功能食品。保健功能食品是指添加到食品原料如饮料、茶中,或通过胶囊化、粉化、混悬等方式制造的食品,这意味着保健功能食品在食用时会对健康产生特定的影响。然而,与一般药物不同,保健功能食品的优势在于,由于使用食品作为原料,所以没有在长时间服用药物时可能会出现副作用。如此获得的本发明的保健功能食品可以每天摄取,因此非常有用。在这样的保健食品中,抗呼吸道病毒组合物的添加量可能因目标保健食品的种类而异,无法统一规定。然而,基于目标食品,抗呼吸道病毒组合物的添加量一般为001至50重量%,优选01至20重量%。此外,在颗粒剂、片剂或胶囊剂形式的食品的情况下,抗呼吸道病毒组合物的添加量通常为01至100重量%,优选05至80重量%。在一个实施方案中,本发明的保健功能食品可以是饮料的形式。
根据本发明的食品组合物或保健功能食品可以有用地用作在施用抗呼吸道病毒治疗剂之前或之后服用的补充剂。
公开的模式
参考以下详细描述的实施方案,本发明的优点和特征以及实现其的方法将变得显而易见。然而,本发明不限于以下公开的实施方案,而是会以各种不同的形式体现,并且只有这些实施方案才使得本发明的公开内容完整并被提供,以便本公开内容将是彻底和完整的,并将本公开内容的方面和特征传达给本领域技术人员。本发明仅由所附权利要求的范围限定。
制备例1:晚红瓦松提取物的制备
为制备晚红瓦松提取物,基于晚红瓦松的重量,将20倍的蒸馏水加入到晚红瓦松中,在115℃下进行热水提取180分钟,并且通过0.45μm的一级过滤、然后0.22μm的二级过滤去除沉淀物。接下来,将pH调节至7.0,并将每1ml过滤产物分配到1.5ml Ep-管中并储存在-20℃以用于所有分析。
制备例2:沙参提取物的制备
将沙参的叶、茎和根风干并粉碎,然后加入10倍甲醇并提取2次,每次12小时。收集滤液,在旋转蒸发器中蒸发溶剂,将剩余的残余物部分取出并冷冻(在-70℃),而其余部分用于顺序溶剂分级。即,在依次用己烷、乙酸乙酯和蒸馏水(水)进行溶剂分级后,在旋转蒸发器中蒸发溶剂并干燥以用作样品。
制备例3:羊乳参、天门冬、玉竹、黄芪、蒲公英、黄芩、干姜、山药、人参、甘草、枣、党参、苍术、贯众、羌活、藿香、陈皮、五味子、枸杞、槐花、菟丝子、丹参、蛇床子、远志和郁金的提取物的制备
将各植物清洗和称重,并按照制备例1的方法制备提取物。
实施例1:
使用制备例1中制备的晚红瓦松提取物。
实施例2:
将制备例1的提取物和制备例2的提取物以10:5的重量比混合,使用混合提取物。
实施例3至5:
通过使用具有下表1所示组成的制备例1至3的提取物制备组合物。
[表1]
实验例1:病毒培养
用于测量实施例1-5中获得的水提物的抗病毒活性的目标病毒为传染性胃肠炎病毒(TGEV)和猪流行性腹泻病毒(PEDV),将TGEV培养在ST细胞中,并且PEDV培养在Vero细胞中。将ST细胞和Vero细胞在37℃培养箱中使用含有10%胎儿血清的基本必需培养基(MEM)培养。
实验例2:病毒抑制能力分析
为了测量实施例1-5中获得的水提物对TGEV的病毒增殖抑制能力,将ST细胞和Vero细胞培养在96孔板中,每种细胞在孔底填充至少90%。去除现有培养基,向每个孔加入含有TGEV的新培养基,向每个孔按浓度(250、500、1000μg/ml培养基)加入各植物提取物。每种提取物的病毒增殖抑制能力通过TGEV感染ST或Vero细胞48小时,然后通过SRB测定法测量活细胞来测量[Martin A,Martin C(1997)Comparison of 5 microplate colorimetricassay for in vitro cytoxicity testing and cell proliferation assayCytotechnology,11:49-54]。向每个孔加入100μl 10%三氯乙酸(TCA),将所得产物4℃放置1小时,并且用蒸馏水清洗数次。在室温下干燥后,加入100μl的04%(w/v)SRB(磺胺罗丹明B)溶解在1%(v/v)乙酸中的溶液并染色30分钟。未与细胞结合的SRB染色溶液用1%(v/v)乙酸洗涤数次,然后再次干燥。用显微镜相机(Zeiss,Model Axivert10)拍摄每个孔底部细胞的形态,并且向每个孔加入100μl10mM Tris溶液(pH 105)以充分溶解细胞结合染料。然后,在560nm处测量吸光度。处理组,包括未用病毒处理的组、仅用植物提取物处理的组(实施例1至3)、仅用病毒处理的组以及用病毒和水溶性提取物处理的组分别用A、B、C、D标记,并且计算各植物提取物的病毒增殖抑制能力(%)[等式1]。
[等式1]
病毒抑制能力(%)=[(D-C)/(B-C)]x100
实验结果1:针对TGEV的抗病毒活性的分析
实施例1至5的所有提取物的针对TGEV的抗病毒活性示于下表2中。实施例1至5表现出较高的病毒增殖抑制能力,并且特别地,实施例5的提取物最高。
表2
Claims (13)
1.一种抗呼吸道病毒组合物,包含晚红瓦松提取物作为活性成分。
2.根据权利要求1所述的抗呼吸道病毒组合物,其中所述呼吸道病毒是选自由以下组成的组的一种或多种:腺病毒、偏肺病毒、鼻病毒、副流感病毒、流感病毒、呼吸道合胞病毒和冠状病毒。
3.根据权利要求1所述的抗呼吸道病毒组合物,其中所述呼吸道病毒是冠状病毒。
4.根据权利要求1所述的抗呼吸道病毒组合物,其中所述大青叶提取物是通过使用选自水和具有1至4个碳原子的醇的一种或多种溶剂提取的。
5.根据权利要求1所述的抗呼吸道病毒组合物,还包含沙参提取物。
6.根据权利要求1所述的抗呼吸道病毒组合物,还包含选自由以下组成的组的一种或多种的提取物:羊乳参、天门冬、玉竹、黄芪、蒲公英、黄芩、干姜、山药、人参、甘草和枣、党参、苍术、贯众、羌活、藿香、陈皮、五味子、枸杞、槐花、菟丝子、丹参、蛇床子、远志和郁金。
7.一种抗呼吸道病毒的药物组合物,包含:根据权利要求1至6中任一项所述的抗呼吸道病毒组合物;和药学上可接受的载体、赋形剂或稀释剂。
8.根据权利要求7所述的药物组合物,其中所述药物组合物具有选自由以下组成的组的剂型:片剂、丸剂、散剂、颗粒剂、胶囊剂、混悬乳剂、糖浆剂、气雾剂、外用制剂、栓剂和注射剂。
9.根据权利要求7所述的药物组合物,所述药物组合物有效用于治疗和预防抗呼吸道病毒相关疾病。
10.一种抗呼吸道病毒的保健功能食品,包含:根据权利要求1-6中任一项所述的抗呼吸道病毒组合物;和食品上可接受的补充添加剂。
11.根据权利要求10所述的保健功能食品,其中所述保健功能食品具有选自由以下组成的组的剂型:散剂、颗粒剂、片剂、胶囊剂、糖果、口香糖、果冻和饮料。
12.根据权利要求10所述的保健功能食品,其中所述保健功能食品是保健功能茶。
13.根据权利要求10所述的保健功能食品,其中所述保健功能食品有效地用于预防呼吸道病毒相关疾病。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200027724A KR102304498B1 (ko) | 2020-03-05 | 2020-03-05 | 항 전염성 위장염 바이러스(tgev)용 조성물 및 이를 포함하는 약학 조성물 |
KR10-2020-0027724 | 2020-03-05 | ||
PCT/KR2020/017454 WO2021177553A1 (ko) | 2020-03-05 | 2020-12-02 | 호흡기 질환의 예방, 개선 또는 효과가 있는 차 조성물 및 이를 포함하는 약학 조성물 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114450018A true CN114450018A (zh) | 2022-05-06 |
Family
ID=77613615
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202080057132.1A Pending CN114450018A (zh) | 2020-03-05 | 2020-12-02 | 具有预防或改善呼吸道疾病的功效的茶组合物及包含该茶组合物的药物组合物 |
Country Status (8)
Country | Link |
---|---|
US (1) | US20220168375A1 (zh) |
EP (1) | EP4115895A4 (zh) |
JP (1) | JP7471393B2 (zh) |
KR (1) | KR102304498B1 (zh) |
CN (1) | CN114450018A (zh) |
CA (1) | CA3152970A1 (zh) |
MX (1) | MX2022002174A (zh) |
WO (1) | WO2021177553A1 (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023172034A1 (ko) * | 2022-03-07 | 2023-09-14 | 기초과학연구원 | 더덕속, 참취속 및/또는 원지속 식물 추출물을 포함하는 외막형 바이러스의 예방 및 치료용 약학 조성물 |
KR102527037B1 (ko) * | 2022-04-20 | 2023-05-02 | 한국 한의학 연구원 | 복합한약재 추출물을 유효성분으로 포함하는 코로나바이러스 감염증의 예방, 개선 또는 치료용 조성물 |
KR102532946B1 (ko) * | 2022-04-20 | 2023-05-17 | 한국 한의학 연구원 | 복합한약재 추출물을 유효성분으로 포함하는 코로나바이러스 감염증의 예방, 개선 또는 치료용 조성물 |
KR102666751B1 (ko) * | 2022-08-25 | 2024-05-16 | 우석대학교 산학협력단 | 벌사상자 추출물을 포함하는 위염 및 위궤양의 예방 또는 치료용 조성물 |
KR102524088B1 (ko) * | 2022-10-27 | 2023-04-21 | 한국 한의학 연구원 | 한약재 추출물을 유효성분으로 포함하는 코로나바이러스 감염증의 예방, 개선 또는 치료용 조성물 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102665742A (zh) * | 2009-11-05 | 2012-09-12 | 韩国韩医学研究院 | 用于预防和治疗流感病毒引起的疾病的组合物 |
CN104758362A (zh) * | 2015-04-26 | 2015-07-08 | 淄博齐鼎立专利信息咨询有限公司 | 中药组合物在制备抗呼吸道合胞病毒药物中的应用 |
CN105213872A (zh) * | 2015-11-10 | 2016-01-06 | 解影影 | 一种治疗感染性呼吸道疾病的药物组合物及其制备方法 |
CN109328066A (zh) * | 2016-04-15 | 2019-02-12 | 同和药品株式会社 | 包含六角英提取物的用于预防或治疗呼吸道疾病的药物组合物 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20140072464A (ko) * | 2012-12-05 | 2014-06-13 | 인제대학교 산학협력단 | 와송 유래 핵산 분획물을 유효성분으로 포함하는 염증 질환의 예방 또는 치료용 조성물 |
KR20150117943A (ko) * | 2014-04-11 | 2015-10-21 | 이남기 | 생약 추출물을 포함하는 항암, 항염 및 항바이러스작용을 하는 약학적 조성물 |
KR101951010B1 (ko) * | 2015-03-27 | 2019-02-22 | 한국 한의학 연구원 | 대청엽 추출물을 유효성분으로 함유하는 선천면역 증진 및 항바이러스용 조성물 |
KR20170003153A (ko) * | 2015-06-30 | 2017-01-09 | 이충렬 | 천문동 추출물을 함유하는 호흡기 질환 예방 및 치료용 조성물 |
KR20170006359A (ko) * | 2015-07-08 | 2017-01-18 | 문병광 | 와송을 이용한 고기능성 와송추출물 및 그 제조방법 |
KR101608476B1 (ko) * | 2015-09-18 | 2016-04-01 | 마옥천 | 와송과 모시잎을 함유하는 빵 그리고 이의 제조방법 |
KR20180040912A (ko) * | 2016-10-13 | 2018-04-23 | 재단법인 제주테크노파크 | 와송 물 추출물을 이용한 면역 증강용 조성물 |
KR102022325B1 (ko) * | 2017-02-01 | 2019-09-18 | (주)옥천당 | 진해, 거담 또는 항염증용 조성물 |
KR101943475B1 (ko) * | 2017-10-31 | 2019-01-29 | 강수용 | 호흡기 질환 예방 및 개선을 위한 식품 조성물 |
CN108339017A (zh) * | 2017-11-30 | 2018-07-31 | 艾美科健株式会社 | 含有壳聚糖和葡萄柚籽提取物作为活性成分的抗病毒用组合物 |
-
2020
- 2020-03-05 KR KR1020200027724A patent/KR102304498B1/ko active IP Right Grant
- 2020-12-02 JP JP2022512465A patent/JP7471393B2/ja active Active
- 2020-12-02 MX MX2022002174A patent/MX2022002174A/es unknown
- 2020-12-02 EP EP20922686.9A patent/EP4115895A4/en active Pending
- 2020-12-02 WO PCT/KR2020/017454 patent/WO2021177553A1/ko unknown
- 2020-12-02 CA CA3152970A patent/CA3152970A1/en active Pending
- 2020-12-02 CN CN202080057132.1A patent/CN114450018A/zh active Pending
-
2022
- 2022-02-23 US US17/678,114 patent/US20220168375A1/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102665742A (zh) * | 2009-11-05 | 2012-09-12 | 韩国韩医学研究院 | 用于预防和治疗流感病毒引起的疾病的组合物 |
CN104758362A (zh) * | 2015-04-26 | 2015-07-08 | 淄博齐鼎立专利信息咨询有限公司 | 中药组合物在制备抗呼吸道合胞病毒药物中的应用 |
CN105213872A (zh) * | 2015-11-10 | 2016-01-06 | 解影影 | 一种治疗感染性呼吸道疾病的药物组合物及其制备方法 |
CN109328066A (zh) * | 2016-04-15 | 2019-02-12 | 同和药品株式会社 | 包含六角英提取物的用于预防或治疗呼吸道疾病的药物组合物 |
Non-Patent Citations (2)
Title |
---|
夏丽英等: "《现代中药毒理学》", 31 October 2005 * |
王艳丰等: "中药抗猪流行性腹泻及作用机制", 《动物医学进展》 * |
Also Published As
Publication number | Publication date |
---|---|
JP2022545288A (ja) | 2022-10-26 |
EP4115895A4 (en) | 2024-04-24 |
KR20210112570A (ko) | 2021-09-15 |
EP4115895A1 (en) | 2023-01-11 |
MX2022002174A (es) | 2022-03-22 |
WO2021177553A1 (ko) | 2021-09-10 |
KR102304498B1 (ko) | 2021-09-23 |
JP7471393B2 (ja) | 2024-04-19 |
CA3152970A1 (en) | 2021-09-10 |
US20220168375A1 (en) | 2022-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114450018A (zh) | 具有预防或改善呼吸道疾病的功效的茶组合物及包含该茶组合物的药物组合物 | |
CN103053953B (zh) | 一种利用药食同用中药材生产的功能型豆芽及方法 | |
KR20110051162A (ko) | 녹용, 산수유, 당귀, 진피, 구기자, 연근, 산약, 울금, 천마, 배초향, 계피, 복분자, 오미자 및 홍삼의 추출물을 유효성분으로 포함하는 면역증강 조성물 | |
Azamthulla et al. | A review on Pterocarpus santalinus Linn | |
KR20110038631A (ko) | 연골 재생, 통증 억제 및 부종 억제용 생약조성물 | |
CN111544543A (zh) | 一种具有清肺、解烟毒及解酒益肝功能的组合物 | |
Li et al. | Lamiophlomis herba: A comprehensive overview of its chemical constituents, pharmacology, clinical applications, and quality control | |
Yaneva et al. | Some endangered healings plants in Bulgaria–legislative regulation, protection, characteristic description, application, agricultural cultivation. | |
CN107297128A (zh) | 可快速净化新装修房屋的空气清新剂 | |
CN107233599B (zh) | 可快速去除空气内金属污染物的空气净化剂 | |
CN106389788A (zh) | 一种用于增强畜禽免疫功能和抗病毒能力的药物提取物、制剂和制备方法 | |
KR102197858B1 (ko) | 혼합 생약 추출물을 유효성분으로 포함하는 건선 예방 또는 치료용 약학적 조성물 | |
KR101028073B1 (ko) | 혈액순환을 개선하여 신체 각 부위를 활성화 시키며 면역력을 증진시키는 작용 및 기전을 가진 조성물과 그 제조방법 | |
KR101768612B1 (ko) | 간기능 개선 효과를 갖는 식품용 조성물 및 이를 이용한 건강차의 제조방법 | |
KR102164421B1 (ko) | 고소애를 포함하는 뼈 성장 및 근섬유 재생 효과를 갖는 한약재 조성물 및 그 제조방법 | |
Craker et al. | Chinese medicinal herbs: Opportunities for domestic production | |
Chaudhary et al. | Concise review on Asparagus racemosus and its role as nutraceuticals and functional foods | |
CN114344434B (zh) | 一种治疗肺结节的中药组合物及其制备方法 | |
CN109646665A (zh) | 杜仲清肺抗癌固体茶及其制备方法 | |
CN109568496B (zh) | 一种治疗糖尿病的中药组合物的检测方法 | |
KR20120041841A (ko) | 여드름 치료 및 피부상태 개선용 한약조성물 | |
CN106139105A (zh) | 一种治疗尿毒症的中药配方 | |
CN100528129C (zh) | 沙枣护发膏及其生产方法 | |
CN108721520A (zh) | 一种用于提高免疫力的口服液及其制备方法 | |
CN105362714A (zh) | 用于治疗口腔癌的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40065317 Country of ref document: HK |